EUVIMEDEUVIMED entdecken
Crossref

Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression

Riyue Feng, Yin Yin, Yuge Wei, Yang Li, Lei Li, Rui Zhu, Xiao Yu, Yuhao Liu, Yahui Zhao, Zhihua Liu

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Riyue Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Exosomes. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

p53 mutations predispose cancer cell development, promote their survival and metastasis, and lead to ineffective therapeutic responses and unfavorable prognosis. No drug that abrogates the oncogenic functions of mutant p53 has been approved for cancer treatment. Here, we performed whole-genome sequencing of 663 esophageal squamous cell carcinoma (ESCC) tumor tissues and paired normal tissues. The results indicated that ESCC samples from our cohort had a more dispersed distribution of TP53 mutants and a higher proportion of nonsense mutants than European and American ESCC samples in the International Agency for Research on Cancer (IARC) database. The most frequent p53 mutations disrupt the inhibition of proliferation, migration, and invasion mediated by wild-type p53 in ESCC. Furthermore, p53 mutations alter its protein nucleoplasmic localization and protein stability. The p53 mutation G245S (p53-G245S) interacts with heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) to increase protein translation of phosphatidylinositol-dependent Arf GAP (AGAP1) by promoting AGAP1 mRNA stability. AGAP1 promotes cancer cell proliferation and metastasis by enhancing exosome formation. Furthermore, we explored the combination of the HSP90 inhibitor HSP90i and the AGAP1 inhibitor QS11 could inhibit ESCC cell proliferation and metastasis. Thus, the p53-G245S/hnRNPA2B1/AGAP1 axis promotes ESCC progression by enhancing exosome formation, and the combination of an HSP90 inhibitor and an AGAP1 inhibitor may serve as a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaExosomesHumansCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticGTPase-Activating ProteinsTumor Suppressor Protein p53Heterogeneous-Nuclear Ribonucleoprotein Group A-B

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaExosomeMetastasisProliferationWhole-genome sequencing

Substanzen

GTPase-Activating ProteinsTumor Suppressor Protein p53AGAP1 protein, humanhnRNP A2Heterogeneous-Nuclear Ribonucleoprotein Group A-B

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, C…

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Meteorological Sciences
  • National Key Research and Development Program of China

Zitieren

APA

Feng, R., Yin, Y., Wei, Y., Li, Y., Li, L., Zhu, R., Yu, X., Liu, Y., Zhao, Y., & Liu, Z. (2023). Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216154

Vancouver

Feng R, Yin Y, Wei Y, Li Y, Li L, Zhu R, et al. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216154

BibTeX
@article{Feng2023,
  author = {Feng, Riyue and Yin, Yin and Wei, Yuge and Li, Yang and Li, Lei and Zhu, Rui and Yu, Xiao and Liu, Yuhao and Zhao, Yahui and Liu, Zhihua},
  title = {Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216154}
}
Kostenlos starten →